DCB Unveiled: Bridging Science and Application – Ep 5: What is the Difference Between the Two Drugs in the Context of DCB?
Join host Dr Rasha Al-Lamee in this exciting new episode, as she is joined by Prof Michael Joner and Prof Bruno Scheller to delve into the distinctive properties of two commonly utilised drugs in the field of DCB.
Increase your understanding of these products by tuning in to this enlightening 15-minute discussion, where you will gain insights on key features and the safety profile, provided with the latest updates from the FDA.
Read MoreRead Less
This podcast series is supported by
Read MoreRead Less
Also listen on
In this episode, Dr Rasha Al-Lamee and Prof Azfar Zaman lead the discussion on managing small vessel disease and the evolving role of DCB in its treatment, including safety considerations when using DCB in small vessels.
Read More
All Episodes
Introducing our new podcast series, DCB Unveiled: Bridging Science and Application, hosted by Dr Rasha Al-Lamee.
Read More
Join host Dr Rasha Al-Lamee in this exciting new episode, as she is joined by Prof Michael Joner and Prof Bruno Scheller to delve into the distinctive properties of two commonly utilised drugs in the field of DCB.
Read More
Join Dr Rasha Al-Lamee and guest Dr Simon Eccleshall as they discuss the pros and cons of the 'leaving nothing behind' strategy and discover when DCB can be advantageous in clinical practice.
Read More
This episode delves into the comparative advantages of DCB against Drug-Eluting Stents (DES) and Plain Old Balloons (POBA).
Read More
In the introductory episode of this new podcast series, Dr Rasha Al-Lamee is joined by Prof Bruno Scheller, a key figure in the initial research on DCB.
Read More